09/10/2026
WHAT CAN WE LEARN FROM THE IGHO UBIRIBO TRAGEDY?
Igho Ubiribo underwent an elective pe**le-enhancement procedure—and never came home.
His death was tragic, unnecessary, and should serve as a wake-up call for our entire industry.
We should not speculate before the investigation is complete. But we must confront an uncomfortable truth: possessing a syringe and purchasing filler do not qualify someone to perform pe**le enhancement.
This is not simply “putting filler in a p***s.”
The p***s has complex vascular anatomy. The injection plane matters. The material matters. The volume matters. Patient selection matters. And when something goes wrong, the person treating you must recognize it immediately and know how to respond.
That requires a real fund of medical knowledge—not a weekend course, an impressive social-media page, or a newly branded procedure.
Over many years, we developed UroFill® as a defined, reproducible technique with physician training, staged low-volume treatments, specific anatomical principles, and protocols for recognizing and managing complications.
No medical procedure is risk-free. But “minimally invasive” does not mean medically trivial.
Patients considering girth enhancement should ask:
Who is holding the syringe?
What is their training?
What technique are they using?
How much are they injecting?
And are they capable of managing an emergency?
The lesson from this tragedy is not that men should be frightened away from pe**le enhancement. It is that this rapidly growing field must demand higher standards, greater transparency, and meaningful physician training.
Because patient health and safety are—and must always remain—non-negotiable.